DiaSorin S.p.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DiaSorin S.p.A. - overview
Established
1968
Location
-, -, Italy
Primary Industry
Biotechnology
About
Founded in 1968 and based in Italy, DiaSorin S. p. A. operates as a provider of immunodiagnostics and molecular diagnostics tests for hospital and private testing laboratories.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.diasorin.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
DiaSorin S.p.A. - timeline of key events
DiaSorin S.p.A. - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 174,839,000 | 197,576,000 | 218,512,000 | 229,776,000 | 253,006,627 | 281,261,000 | 300,014,000 | 332,218,000 | 364,079,000 | 395,079,000 | 881,305,000 | 1,237,654,000 | - | - | - |
| % Revenue Growth (YoY) | - | 13.0% | 10.6% | 5.2% | 10.1% | 11.2% | 6.7% | 10.7% | 9.6% | 8.5% | 123.1% | 40.4% | - | - | - |
| EBITDA (USD) | 26,928,000 | 40,569,000 | 47,011,000 | 57,513,000 | 64,392,619 | 68,615,000 | 80,409,000 | 89,696,000 | 105,770,000 | 105,067,000 | 385,260,000 | 515,492,000 | - | - | - |
| Operating Income (USD) | 17,577,000 | 28,523,000 | 35,315,000 | 46,521,000 | 52,794,619 | 56,273,000 | 67,131,000 | 75,189,000 | 87,807,000 | 83,778,000 | 324,226,000 | 419,499,000 | - | - | - |
| Operating Margin | 10.1% | 14.4% | 16.2% | 20.2% | 20.9% | 20.0% | 22.4% | 22.6% | 24.1% | 21.2% | 36.8% | 33.9% | - | - | - |
| % EBITDA Margin | 15.4% | 20.5% | 21.5% | 25.0% | 25.5% | 24.4% | 26.8% | 27.0% | 29.1% | 26.6% | 43.7% | 41.7% | - | - | - |
| NET Income (USD) | 69,929,000 | 95,759,000 | 92,382,000 | 81,836,000 | 56,622,453 | 46,004,000 | 60,280,000 | 88,587,000 | 100,097,000 | 113,648,000 | 248,296,000 | 310,732,000 | - | - | - |
| % Net Margin | 40.0% | 48.5% | 42.3% | 35.6% | 22.4% | 16.4% | 20.1% | 26.7% | 27.5% | 28.8% | 28.2% | 25.1% | - | - | - |
DiaSorin S.p.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPO | Completed | DiaSorin S.p.A. | - | ||||||||
| Buyout | Completed | DiaSorin S.p.A. | - |
Displaying 1 - 2 of 2
DiaSorin S.p.A. - employee data
DiaSorin S.p.A. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman of the Board of Statutory Auditors | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.